v2.2
Contact
News
Diagnosing DIRD
Browse
Available on AppStore
The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Dijon, France
Browse by »
Drugs
Patterns
XV.aa
Path: Foreign body bronchiolitis (see also IVi)
Last update :
01/01/1970
Causative drugs
3
Charcoal, activated (aspirated)
I.s
I - Interstitial/parenchymal lung disease
I.s - A mass or masses
II.b
II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury
IV.c
IV - Airway involvement
IV.c - Obliterative bronchiolitis (a pattern consistent with) (see also IVn, XVx)
IV.r
IV - Airway involvement
IV.r - Airway pigmentation (black, bluish, petechial)
V.x
V - Pleural and/or pericardial involvement
V.x - Black pleural effusion
XV.q
XV - Pathology
XV.q - Path: Foreign body deposits/granulomatous reaction
XV.aa
XV - Pathology
XV.aa - Path: Foreign body bronchiolitis (see also IVi)
XXIV.k
XXIV - Veterinary medicine
XXIV.k - Veterinary: Granulomatous interstitial pneumonia
1
Propolis
XI.g
XI - Miscellaneous
XI.g - Aspiration, aspiration pneumonia (w/wo demonstrable pharyngeal dysmotility)
XV.aa
XV - Pathology
XV.aa - Path: Foreign body bronchiolitis (see also IVi)
XVI.ai
XVI - Imaging
XVI.ai - Imaging: A 'tree-in-bud' pattern
1
Psyllium
IV.a
IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma
IV.b
IV - Airway involvement
IV.b - Bronchospasm and angioedema
IV.f
IV - Airway involvement
IV.f - Severe or catastrophic bronchospasm or asthma attack (can be fatal)
IV.aa
IV - Airway involvement
IV.aa - Occupational asthma
VIII.a
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.a - Angioedema (may cause UAO, asphyxia and death)
X.f
X - Systemic/Distant conditions, syndromes and reactions
X.f - Anaphylaxis-Anaphylactoid reaction (can be fatal)
XV.aa
XV - Pathology
XV.aa - Path: Foreign body bronchiolitis (see also IVi)
1
1
Search
Search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist